- Nachrichtendetail
-
18.06.2024 14:05:04 - dpa-AFX: *LIGAND SAYS MERCK RECEIVES FDA APPROVAL FOR PNEUMOCOCCAL 21-VALENT CONJUGATE VACCINE FOR ADULTS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Merck & Co | A0YD8Q | NYSE | 126,040 | 09.07.24 21:59:59 | +0,260 | +0,21% | 125,350 | 126,500 | 126,800 | 125,780 |
|
Ligand Pharmaceuticals | A1C9RN | NASDAQ | 91,710 | 09.07.24 22:00:10 | +4,830 | +5,56% | 91,000 | 91,910 | 87,780 | 86,880 |
